Ovarian Cancer Market | DataM IntelligenceThe key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the ovarian cancer market globally. The key players operating in the global ovarian cancer market are Roche, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Celgene, Amgen, Pfizer, and Merck.Ovarian Cancer Market Growth Trends Outlook
According to the research report published by the DataM Intelligence, the global Ovarian Cancer Market size is projected to reach USD billion by the end of 2029, with growth at a CAGR of 16% during the forecast period 2022-2029.
Ovarian cancer is the deadly gynecological cancer and is the seventh most common cancer in women globally. Most women with ovarian cancer are diagnosed at the advanced stage, which is most challenging to treat. Chemotherapy and Surgery are usually used in the treatment of ovarian cancer.
The major driving forces are rising ovarian cancer incidence, a growing number of clinical trials for innovations, increasing health expenditure, the use of combination therapies to treat ovarian cancer, and the increasing geriatric population.
The presence of increased funding for ovarian cancer research is expected to boost the market. However, the high cost of cancer treatment, lack of accurate diagnosis of ovarian cancer, and lack of awareness in emerging and low-income economies are expected to restrain the market.
Immunotherapy is expected to boost market growth over the forecast period. This is owing to the presence of ongoing research activities by various universities.
To know more insights on Market Size, Demand, and Company Profile Analysis, Kindly Download Our Sample Brochure @ https://www.datamintelligence.com/download-sample/ovarian-cancer-market
Regional Insights:
North America was dominating the global ovarian cancer market in 2018. It is estimated to hold a significant market size over the forecast period (2020-2027) due to the increasing incidence of ovarian cancer and ongoing research activities
Asia-Pacific is expected to dominate the global ovarian cancer market during the forecast period. The rising incidence and the presence of increased funding for ovarian cancer research are driving the market. For instance, according to a news published in Ovarian Cancer News Today, in August 2019, a $566,000 grant was awarded through the Ovarian Cancer Research Foundation.
Some of the Major Companies Leading the Global Market:
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the ovarian cancer market globally. The key players operating in the global ovarian cancer market are Roche, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Celgene, Amgen, Pfizer, and Merck.
Market Segmentation:
By Type:
Epithelial ovarian cancer
Germ cell ovarian cancer
Stromal cell ovarian cancer
Small cell ovarian cancer
By Treatment Type:
Targeted Therapy
Surgery
Chemotherapy
Immunotherapy
Others
By Diagnosis type:
Blood tests
Imaging tests
Laparoscopy
Colonoscopy
Others
By Drug Class:
PARP Inhibitors
Angiogenesis Inhibitors
PD-L1 Inhibitors
By End-user:
Hospitals
Clinics
Cancer centers
Others
Geographical Classification:
North America
Latin America
Europe
Middle East and Africa
Asia Pacifica
Rest of the world
Make an Inquire before purchasing full report @ https://www.datamintelligence.com/enquiry/ovarian-cancer-market
The Full Report has the below insights.
- The report offers a comprehensive evaluation of the market in terms of Market Value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data (2020-2021), and verifiable projections about market size during the forecast period (2022-2029).
- Visualize the composition of the Ovarian Cancer Market Segmentation By Type, By Treatment Type, By Diagnosis Type, By Drug Class, By End User, and Region, highlighting the key commercial assets and players.
- Identify commercial opportunities in the Market by analyzing trends and co-development deals.
- The report also covers data insights on various industry forces such as porter's five forces, regulations in each country, reimbursement scenario, technological advancements, PEST analysis, and pricing analysis.
- Excel data sheet with thousands of Market-level 4/5 segmentation data points.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
- The report will provide access to approximately 50+ market data tables, 40+ figures, and close to 180 pages.
Additional Benefits Post Purchase:
- Unlimited Analyst support for a period of 1 year.
- Any query regarding the scope offered will be addressed within 24- 48 hours.
- An excel sheet with market numbers will be provided separately
Media Contact
Company Name: DataM Intelligence
Contact Person: Sai
Email: Send Email
Phone: +1 877 441 4866
Country: United States
Website: https://www.datamintelligence.com/research-report/ovarian-cancer-market
